Singapore markets close in 48 minutes

Straits Times Index
3,129.46
+13.14(+0.42%)
Nikkei
28,455.60
+528.23(+1.89%)
Hang Seng
23,973.28
+623.90(+2.67%)
FTSE 100
7,232.28
0.00(0.00%)
BTC-USD
50,914.64
+2,238.52(+4.60%)
CMC Crypto 200
1,319.45
+59.29(+4.71%)

AIRLINES

Omicron’s rapid spread shreds budding recovery in air travel

BioCryst Pharmaceuticals, Inc. (BCRX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD

Add to watchlist

11.18

-0.26

(-2.27%)

At close: 04:00PM EST

11.34

+0.16

(+1.43%)

After hours:

07:59PM EST

Loading interactive chart…

Zacks
BioCryst (BCRX) Begins Enrollment in PNH Study on BCX9930
BioCryst (BCRX) starts patient enrollment in the pivotal REDEEM-2 study evaluating BCX9930 for treating patients with paroxysmal nocturnal hemoglobinuria.
Motley Fool
3 Incredibly Cheap Growth Stocks That Could Make You a Millionaire
Bionano Genomics, BioCryst Pharmaceuticals, and NRx Pharmaceuticals all have the potential to make their early shareholders rich.
Motley Fool
BioCryst Pharmaceuticals (BCRX) Q3 2021 Earnings Call Transcript
Participating with me today are CEO Jon Stonehouse; CFO Anthony Doyle; Chief Commercial Officer Charlie Gayer; Chief Medical Officer Dr. Three quarters of the way into 2021, and this has been an amazing year of execution for our company.